FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

424725004: Agalsidase beta (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2007. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3688105010 Agalsidase beta (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3688106011 Agalsidase beta en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
53581000195115 agalsidasi beta it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
523901000188114 agalsidase bêta fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
68491000195118 Agalsidase beta de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Agalsidase beta (substance) Is a Alpha-galactosidase false Inferred relationship Some
Agalsidase beta (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Hydrolase (disposition) true Inferred relationship Some
Agalsidase beta (substance) Is a Galactosidase true Inferred relationship Some
Agalsidase beta (substance) Is a Recombinant protein (substance) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Agalsidase beta 5 mg powder for solution for injection vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Agalsidase beta (substance) Inferred relationship Some
Agalsidase beta 35 mg powder for solution for injection vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Agalsidase beta (substance) Inferred relationship Some
Product containing agalsidase beta (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Agalsidase beta (substance) Inferred relationship Some 1
Agalsidase beta 5 mg powder for solution for injection vial This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Agalsidase beta (substance) Inferred relationship Some 1
Agalsidase beta 5 mg powder for solution for injection vial The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Agalsidase beta (substance) Inferred relationship Some 1
Agalsidase beta 35 mg powder for solution for injection vial The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Agalsidase beta (substance) Inferred relationship Some 1
Agalsidase beta 35 mg powder for solution for injection vial This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Agalsidase beta (substance) Inferred relationship Some 1
Agalsidase beta-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Agalsidase beta (substance) Inferred relationship Some 1
Product containing only agalsidase beta (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Agalsidase beta (substance) Inferred relationship Some 1
Agalsidase beta only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Agalsidase beta (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start